The development in oncoimmunology was based on the identification of highly diverse tumor-infiltrating lymphocyte (TIL) populations, such as natural killer (NK) and CD8+ cells, that have antagonistic function in the tumor niche [2]. The gene discussed is CD8A; the disease is neoplasm.